Screener
Cumberland Pharmaceuticals CPIX Total Revenue
Total Revenue at other companies
Segments
Other financials
Where this comes from
Reported directly by Cumberland Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The source filing: Cumberland Pharmaceuticals’s 10-Q, filed August 7, 2026.
- Filed
- Aug 7, 2026, 5:12 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001087294-26-000062
| Line item | Three months ended June 30, 2026 | Three months ended June 30, 2025 | Six months ended June 30, 2026 | Six months ended June 30, 2025 |
|---|---|---|---|---|
| Net revenues from continuing operations | $166,458 | $380,797 | $330,308 | $547,425 |
| Costs and expenses: | ||||
| Research and development | 772,162 | 837,401 | 1,538,007 | 1,522,188 |
| General and administrative | 2,547,606 | 2,657,146 | 4,870,980 | 4,855,889 |
| Amortization | 7,151 | 5,769 | 14,152 | 11,844 |
| Total costs and expenses | 3,326,919 | 3,500,316 | 6,423,139 | 6,389,921 |
| Operating loss | (3,160,461) | (3,119,519) | (6,092,831) | (5,842,496) |
| Interest income | 60,884 | 127,489 | 138,915 | 253,198 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Cumberland Pharmaceuticals's total revenue?
- Cumberland Pharmaceuticals (CPIX) reported total revenue of $166.46K in Q2 2026.
- How has Cumberland Pharmaceuticals's total revenue changed year-over-year?
- Cumberland Pharmaceuticals's total revenue decreased by 56.3% year-over-year, from $380.8K to $166.46K.
- What is the long-term trend for Cumberland Pharmaceuticals's total revenue?
- Over 4 years (2021 to 2025), Cumberland Pharmaceuticals's total revenue has grown at a -1.4% compound annual growth rate (CAGR), from $35.99M to $34.06M.
- What does total revenue mean?
- The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.
Ask your AI about Cumberland Pharmaceuticals's total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude